Assessment of second-line antiretroviral regimens for HIV therapy in Africa

BACKGROUND: The efficacy and toxic effects of nucleoside reverse-transcriptase inhibitors (NRTIs) are uncertain when these agents are used with a protease inhibitor in second-line therapy for human immunodeficiency virus (HIV) infection in resource-limited settings. Removing the NRTIs or replacing t...

Полное описание

Библиографические подробности
Главные авторы: Paton, N, Kityo, C, Walker, A, al., E
Формат: Journal article
Язык:English
Опубликовано: Massachusetts Medical Society 2014

Схожие документы